| Autor: |
Pinkerton, A. B., Vernier, J.-M., Schaffhauser, H., Rowe, B. A., Campbell, U. C., Rodriguez, D. E., Lorrain, D. S., Baccei, C. S., Daggett, L. P., Bristow, L. J. |
| Zdroj: |
Journal of Medicinal Chemistry; August 2004, Vol. 47 Issue: 18 p4595-4599, 5p |
| Abstrakt: |
Herein we disclose the discovery of a new class of positive allosteric potentiators of the metabotropic glutamate receptor 2 (mGlu2), phenyl-tetrazolyl acetophenones, e.g. 1-(2-hydroxy-3-propyl-4-{4-[4-(2H-tetrazol-5-yl)phenoxy]butoxy}phenyl) ethanone (4). These potentiators were shown to have no effect in the absence of glutamate as well as no effect at mGlu3 or the other mGlu receptors. The compounds were also evaluated in rodent models with potential relevance for schizophrenia, and 4 was shown to have activity in the inhibition of ketamine-induced norepinephrine release and ketamine-induced hyperactivity. This represents the first example of the efficacy of mGlu2 receptor potentiators in these models. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
